Epstein-Barr virus--is it time to develop a vaccine program?
D000349:Africa; D002051:Burkitt Lymphoma / Q000209:etiology / Q000517:prevention & control*; D004279:DNA, Viral / Q000032:analysis; D005069:Evaluation Studies as Topic; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D009303:Nasopharyngeal Neoplasms / Q000517:prevention & control*; D012449:Safety; D014611:Vaccination; D014765:Viral Vaccines / Q000008:administration & dosage
D004279:DNA, Viral; D014765:Viral Vaccines